宏达高科:2025一季报净利润0.18亿 同比下降0%

Financial Data and Indicators - The basic earnings per share for Q1 2025 remained unchanged at 0.1000 CNY compared to Q1 2024 [1] - The net asset per share increased by 3.27% to 11.7 CNY from 11.33 CNY in the previous year [1] - The undistributed profits per share rose by 5.57% to 5.12 CNY from 4.85 CNY in Q1 2024 [1] - The operating revenue for Q1 2025 was 1.23 billion CNY, a 1.65% increase from 1.21 billion CNY in Q1 2024 [1] - The net profit for Q1 2025 remained stable at 0.18 billion CNY, the same as Q1 2024 [1] - The return on equity decreased slightly to 0.86% from 0.89% in the previous year [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 31.1774 million shares, accounting for 22.66% of the circulating shares, with a decrease of 727,100 shares from the previous period [1] - Notable shareholders include Shen Guofu with 10.65 million shares (7.74%), Bai Ning with 4.35 million shares (3.16%), and Li Hong with 3.96 million shares (2.88%), all of whom maintained their holdings [2] - New entrants among the top shareholders include Shen Huilian, Zhang An, Xing Chuzhi, and Zhang Jianfu, while Lu Hongping, Yu Hongtao, Wang Zongli, and Shen Jianlin exited the top ten list [2] Dividend Distribution - The company has announced that there will be no distribution or transfer of dividends this time [3]